Clinical Trial Update: Perioperative Toripalimab (JS001) Combined With Neoadjuvant Chemotherapy in Patients With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating perioperative toripalimab in combination with neoadjuvant chemotherapy for patients with resectable locally advanced thoracic esophagea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING